AMJEVITA (adalimumab-atto)

**Product type:** Human Prescription Drug

**Active ingredient:** ADALIMUMAB

**Strength:** 40 mg/.4mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Amgen USA Inc.

**Marketing category:** BLA (BLA761024)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]